Germany· DE-A57-5912416cbf03d77e

Rudotel

A medazepam product containing medazepam, registered in Germany by Teva Gmbh. The same ATC class is registered in 4 of our 19 countries.

ATC N05BA03

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedRudotelATCN05BA03REGISTER NO.DE-A57-5912416cbf03d7…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Medazepam is registered in 4 of 19 countries.

Countries holding a registration under ATC N05BA03 (medazepam), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 2 of them publish a price we can compare per daily dose

Medazepam · ATC N05BA03

4 / 19 countries

  • Finlandprice
  • Germany
  • Japan
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Medazepam
Manufacturer
Teva Gmbh
Country
Germany (DE)
ATC code
N05BA03
ATC class
Medazepam
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Medazepam in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All medazepam products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Hungary · Medazepam Teva, Rudotel
  • Lithuania · Rudotel
  • Poland · Medazepam Tzf
  • Romania · Medazepam Arena, Medazepam Laropharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/95d434d7-c8b0-48c0-b3c5-f5ab14dda62a
GET /v1/drugs/95d434d7-c8b0-48c0-b3c5-f5ab14dda62a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Medazepam",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about medazepam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.